Navigate
PricingCore TherapiesHow It WorksTools
More
MembersCreatorsCommunity
Sign InGet Started
Physician-Supervised

Protocols tailored to your goals, not one-size-fits-all prescriptions.

Every protocol is personalized by a licensed provider based on your history, goals, labs, and medical eligibility.

4.9100+ customers50+ reviews

Trusted by leading health platforms

CLIA Certified
CAP Accredited
Trustpilot
Prenuvo
Path
Spio Health
VitaminLab
ProHealth Longevity
LVLUP Health
CLIA Certified
CAP Accredited
Trustpilot
Prenuvo
Path
Spio Health
VitaminLab
ProHealth Longevity
LVLUP Health

How protocols are chosen

Your provider considers multiple factors to build a protocol that fits your unique situation.

Your goals
Medical history
Current medications
Biomarker data
Provider judgment

Compare by goal

Filter therapies by what matters most to you. Tap any card to learn more.

SEMA/B6 (reconstituted)

SEMA/B6 (reconstituted)

GLP-1

2.5–5 mg/mL | 1–5 mL

Prescription onlyCompounded in the USA

GLP-1 receptor agonist with pyridoxine (B6) prescribed for appetite regulation, blood sugar support, and weight management when clinically appropriate.

Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. (STEP 1 trial)

SEMA/B6 mimics the GLP-1 hormone to slow gastric emptying, reduce hunger signals, and support insulin sensitivity. Combined with pyridoxine (vitamin B6) for enhanced tolerability. In the STEP 1 clinical trial, participants experienced an average of 14.9% body weight reduction over 68 weeks compared to placebo. Individual results vary. Compounded SEMA/B6 is not FDA-approved.

TIRZ/B3 (reconstituted)

TIRZ/B3 (reconstituted)

GLP-1

10–20 mg/mL | 1–3 mL

Prescription onlyCompounded in the USA

Dual GIP/GLP-1 receptor agonist with niacinamide prescribed for appetite regulation and metabolic support when clinically appropriate.

Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. (SURMOUNT-1 trial)

TIRZ/B3 activates both GIP and GLP-1 receptors for enhanced metabolic support. Combined with niacinamide for improved stability and tolerability. In the SURMOUNT-1 trial, participants receiving the highest dose experienced up to 22.5% body weight reduction over 72 weeks compared to placebo. Individual results vary. Compounded TIRZ/B3 is not FDA-approved.

NAD+ (reconstituted)

NAD+ (reconstituted)

Longevity

200 mg/mL | 5 mL

Prescription onlyCompounded in the USA

Coenzyme involved in cellular energy production and DNA repair. Compounded injectable. Not FDA-approved.

Massudi H, et al. Age-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue. PLoS One. 2012;7(7):e42357.

NAD+ is a coenzyme involved in hundreds of metabolic processes. Published research suggests NAD+ levels decline with age. This compounded injectable preparation is not FDA-approved for any medical condition. Individual responses vary. Prescribed when clinically appropriate.

Sermorelin (reconstituted)

Sermorelin (reconstituted)

Growth Hormone

3MG 5ML

Prescription onlyCompounded in the USA

Growth hormone-releasing hormone analog that stimulates natural GH production. Compounded preparation.

Sermorelin is a GHRH analog that stimulates the pituitary gland to produce and release growth hormone naturally. It supports improved recovery, sleep quality, and body composition. Sermorelin (Geref) previously had FDA approval but was discontinued for commercial reasons. This compounded preparation is prescribed when clinically appropriate.

Glutathione (reconstituted)

Glutathione (reconstituted)

Antioxidant

200 mg/mL | 10–30 mL

Prescription onlyCompounded in the USA

Endogenous antioxidant supporting cellular protection. Compounded injectable form. Not FDA-approved.

Glutathione is the body's most abundant endogenous antioxidant, involved in liver detoxification and immune cell function. Injectable delivery bypasses digestive breakdown. This compounded preparation is not FDA-approved for any specific medical condition. Prescribed when clinically appropriate.

PT-141 (Bremelanotide)

PT-141 (Bremelanotide)

Sexual Wellness

Multiple formats

Prescription onlyCompounded in the USA

Melanocortin receptor agonist for sexual arousal and desire. Available as nasal spray, capsule, and troche.

PT-141 (Bremelanotide) works centrally on the nervous system via melanocortin receptors to enhance sexual arousal and desire in both men and women. The FDA-approved version (Vyleesi) is indicated for hypoactive sexual desire disorder in premenopausal women. Compounded formulations are available in multiple delivery formats including nasal sprays, capsules, and troches. Prescribed when clinically appropriate.

Oxytocin (reconstituted)

Oxytocin (reconstituted)

Sexual Wellness

2mg 3ML

Prescription onlyCompounded in the USA

Neuropeptide supporting emotional bonding, stress reduction, and sexual well-being. Available as troche and RDT.

Oxytocin is a naturally occurring neuropeptide that promotes social bonding, reduces stress and anxiety, and supports emotional and sexual well-being. Available in sublingual troches and rapidly dissolving tablets (RDTs). Compounded formulations are not FDA-approved. Prescribed when clinically appropriate.

All medications require a valid prescription from a licensed healthcare provider following a clinical evaluation. Not all patients will qualify for all treatments.

Ready to get started?

Choose a membership plan and get matched with a physician who will build your personalized protocol.

Medical Disclaimer: All therapies listed require physician evaluation and prescription. CULTR Health does not guarantee specific results. Outcomes vary by individual. If you have a medical emergency, call 911.

Stop guessing. Start optimizing.

Take the 2-minute quiz to find your protocol.

CULTR Health